The hostile tumor microenvironment (TME) harbors mechanisms to suppress or subvert both the innate and adaptive immune response, resulting in unchecked tumor progression. So, what do we do? Investigate.
Join our webinar to improve your understanding of the cellular and molecular mechanisms of the TME and learn about new technologies that allow us to interrogate this complex biological environment. You’ll discover in vitro and in vivo immune-mediated tumor killing models that can predict efficacy and the mechanism of action of established and emerging therapeutics.
Robert Nunan, PhD
Group Leader, Charles River